🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Amlitelimab

Found 18 matching trials

Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

PHASE2

This is a parallel, Phase 2, 2-arm, double-blind, randomized, multicenter, ...

Status

Terminated

Location

Medical Dermatology Specialists Site Number : 8400002

Start Date

2023-11-01

Trial ID

NCT06118099

Treatments Being Tested

Amlitelimab Placebo

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

PHASE3

This is a parallel group, Phase 3, multinational, multicenter, randomized, ...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham- Site Number : 8401267

Start Date

2024-02-29

Trial ID

NCT06241118

Treatments Being Tested

Amlitelimab Placebo Topical corticosteroids Topical tacrolimus or pimecrolimus

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

PHASE3

This is a parallel group, Phase 3, multinational, multicenter, randomized, ...

Status

Completed

Location

Cahaba Dermatology & Skin Health Center- Site Number : 8401066

Start Date

2024-01-18

Trial ID

NCT06224348

Treatments Being Tested

Amlitelimab Placebo Topical corticosteroids Topical calcineurin inhibitors

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

PHASE2

This is a Phase 2, multicenter, randomized, double-blind placebo controlled...

Status

Completed

Location

Clinical Research Center of Alabama - Homewood- Site Number : 8401101

Start Date

2023-10-06

Trial ID

NCT06015308

Treatments Being Tested

Amlitelimab Placebo Tdap vaccine PPS vaccine

A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants

PHASE1

This is a 2-part, Phase 1 study, with 1 arm in Part 1 and a randomized para...

Status

Completed

Location

Clinical Pharmacology of Miami-Site Number: 8400001

Start Date

2022-04-28

Trial ID

NCT05796479

Treatments Being Tested

Amlitelimab DP1 Amlitelimab DP2

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

PHASE3

This is a multinational, multicenter, randomized, double-blind, placebo-con...

Status

Active Not Recruiting

Location

Cahaba Dermatology & Skin Health Center- Site Number : 8401066

Start Date

2024-05-08

Trial ID

NCT06407934

Treatments Being Tested

Amlitelimab Placebo

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

PHASE2

This is an open-label, Phase 2/Phase 3, long-term extension study for treat...

Status

Active Not Recruiting

Location

Allervie Clinical Research - Birmingham- Site Number : 8401101

Start Date

2022-08-22

Trial ID

NCT05492578

Treatments Being Tested

Amlitelimab Topical corticosteroids Topical calcineurin inhibitors Oral corticosteroids

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

PHASE2

This was a parallel, Phase 2, global, multicenter, randomized, double-blind...

Status

Completed

Location

University of California San Diego Health Site Number : 8400026

Start Date

2022-06-30

Trial ID

NCT05421598

Treatments Being Tested

Amlitelimab Placebo

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

PHASE2

This is a study of amlitelimab for the treatment of participants with moder...

Status

Active Not Recruiting

Location

Bensch Research Associates- Site Number : 8400004

Start Date

2023-09-05

Trial ID

NCT06033833

Treatments Being Tested

Amlitelimab Placebo

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

PHASE3

This is a parallel group, Phase 3, multinational, multicenter, randomized, ...

Status

Completed

Location

Scottsdale Clinical Trials- Site Number : 8401149

Start Date

2023-11-08

Trial ID

NCT06130566

Treatments Being Tested

Amlitelimab Placebo

Previous Next